Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|September 5, 2024
Development of Tailless Homologue Receptor (TLX) Agonist Chemical ToolsEmily C Hank, Minh Sai, Till Kasch, et al.
Scientific Reports|October 2, 2015
NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X ReceptorJurema Schmidt, Franca-Maria Klingler, Ewgenji Proschak, et al.
Chemmedchem|September 12, 2023
Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer AgonismDaniel Zaienne, Laura Isigkeit, Julian A Marschner, et al.
Journal of Medicinal Chemistry|May 31, 2023
De Novo Design of Nurr1 Agonists via Fragment-Augmented Generative Deep Learning in Low-Data RegimeMarco Ballarotto, Sabine Willems, Tanja Stiller, et al.
Visnyk Kyivs'Koho Natsional'Noho Universytetu Imeni Tarasa Shevchenka. Biolohiia|January 13, 2021
THE EFFECT OF COMPOUND DM509 ON KIDNEY FIBROSIS IN THE CONDITIONS OF THE EXPERIMENTAL MODELA Stavniichuk, O Savchuk, Abdul Hye Khan, et al.
Bioorganic & Medicinal Chemistry|January 14, 2015
Anthranilic acid derivatives as nuclear receptor modulators--development of novel PPAR selective and dual PPAR/FXR ligandsDaniel Merk, Christina Lamers, Julia Weber, et al.
Communications Chemistry|February 3, 2025
Chemogenomics for steroid hormone receptors (NR3)Espen Schallmayer, Laura Isigkeit, Lewis Elson, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
A New FXR Ligand Chemotype with Agonist/Antagonist SwitchMoritz Helmstädter, Jan Vietor, Jana Sommer, et al.
ACS Medicinal Chemistry Letters|February 21, 2019
Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist ChemotypePascal Heitel, Leonie Gellrich, Lena Kalinowsky, et al.
Communications Chemistry|May 21, 2025
Structural and mechanistic profiling of Nurr1 modulation by vidofludimus enables structure-guided ligand designÚrsula López-García, Jan Vietor, Julian A Marschner, et al.
Pageof 16